Skip to main content
Press release February 19, 2026

Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease

Serina Therapeutics, Inc. (SER)

Please enable cookies. Error 1015 Ray ID: a13677e83bca8df4 • 2026-06-29 16:57:06 UTC You are being rate limited What happened? The owner of this website (investors.serinatx.com) has banned you temporarily from accessing this website. Please see https://developers.cloudflare.com/support/troubleshooting/http-status-codes/cloudflare-1xxx-errors/error-1015/ for more details. Was this page helpful? Yes No Thank you for your feedback! Cloudflare Ray ID: a13677e83bca8df4 • Your IP: Click to reveal 81.193.37.7 • Performance & security by Cloudflare
View original release